Press Releases :: Nighthawk Biosciences, Inc. (NHWK)

Nov 14, 2022 4:01pm EST

NightHawk Biosciences Provides Third Quarter 2022 Business Update

Oct 21, 2022 8:00am EDT

Nighthawk Biosciences’ Scorpion Subsidiary Announces Grand Opening of its San Antonio Facility

Aug 23, 2022 7:30am EDT

NightHawk Biosciences Announces Buildout of Advanced Biosafety Level 2 (BSL-2) Laboratory

Aug 10, 2022 4:05pm EDT

NightHawk Biosciences Provides Second Quarter 2022 Business Update

Jun 13, 2022 8:00am EDT

NightHawk Biosciences Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer of Scorpion Biological Services

May 16, 2022 4:44pm EDT

NightHawk Biosciences Provides First Quarter 2022 Business Update

May 10, 2022 8:00am EDT

NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35

May 03, 2022 7:00am EDT

Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open Today

Apr 27, 2022 8:00am EDT

Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian Government

Apr 20, 2022 8:00am EDT

Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics

rss_feed News RSS

OUR ECOSYSTEM